329 related articles for article (PubMed ID: 21633170)
1. Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.
Pabla N; Dong G; Jiang M; Huang S; Kumar MV; Messing RO; Dong Z
J Clin Invest; 2011 Jul; 121(7):2709-22. PubMed ID: 21633170
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase C
Zhang D; Pan J; Xiang X; Liu Y; Dong G; Livingston MJ; Chen JK; Yin XM; Dong Z
J Am Soc Nephrol; 2017 Apr; 28(4):1131-1144. PubMed ID: 27799485
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z
Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117
[TBL] [Abstract][Full Text] [Related]
4. Protein Kinase C-
Zhu J; Zhang G; Song Z; Xiang X; Shu S; Liu Z; Yang D; Wei Q; Dong Z
J Am Soc Nephrol; 2020 May; 31(5):1050-1065. PubMed ID: 32291286
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity.
Sun L; Liu J; Yuan Y; Zhang X; Dong Z
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F469-F478. PubMed ID: 29767555
[TBL] [Abstract][Full Text] [Related]
6. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
[TBL] [Abstract][Full Text] [Related]
8. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.
Song Z; Zhu J; Wei Q; Dong G; Dong Z
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1041-F1052. PubMed ID: 32150448
[TBL] [Abstract][Full Text] [Related]
9. Activation and involvement of p53 in cisplatin-induced nephrotoxicity.
Wei Q; Dong G; Yang T; Megyesi J; Price PM; Dong Z
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1282-91. PubMed ID: 17670903
[TBL] [Abstract][Full Text] [Related]
10. PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy.
Berardi DE; Flumian C; Rodriguez CE; Bessone MI; Cirigliano SM; Joffé ED; Fiszman GL; Urtreger AJ; Todaro LB
J Cell Biochem; 2016 Mar; 117(3):730-40. PubMed ID: 26335446
[TBL] [Abstract][Full Text] [Related]
11. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.
Wang Y; Tang C; Cai J; Chen G; Zhang D; Zhang Z; Dong Z
Cell Death Dis; 2018 Nov; 9(11):1113. PubMed ID: 30385753
[TBL] [Abstract][Full Text] [Related]
12. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress contributes to cisplatin-induced chronic kidney disease via the PERK-PKCδ pathway.
Shu S; Wang H; Zhu J; Fu Y; Cai J; Chen A; Tang C; Dong Z
Cell Mol Life Sci; 2022 Jul; 79(8):452. PubMed ID: 35895146
[TBL] [Abstract][Full Text] [Related]
14. PRKCD/PKCδ contributes to nephrotoxicity during cisplatin chemotherapy by suppressing autophagy.
Zhang D; Xu X; Dong Z
Autophagy; 2017 Mar; 13(3):631-632. PubMed ID: 28059582
[TBL] [Abstract][Full Text] [Related]
15. Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment.
Pabla N; Dong Z
Oncotarget; 2012 Jan; 3(1):107-11. PubMed ID: 22403741
[TBL] [Abstract][Full Text] [Related]
16. Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function.
Maimaitiyiming H; Li Y; Cui W; Tong X; Norman H; Qi X; Wang S
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F881-90. PubMed ID: 23825069
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.
Chen Z; Forman LW; Miller KA; English B; Takashima A; Bohacek RA; Williams RM; Faller DV
Endocr Relat Cancer; 2011 Dec; 18(6):759-71. PubMed ID: 21990324
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.
Reyland ME; Jones DN
Pharmacol Ther; 2016 Sep; 165():1-13. PubMed ID: 27179744
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein kinase (PK) Cδ attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2A and PKA.
Dang DK; Duong CX; Nam Y; Shin EJ; Lim YK; Jeong JH; Jang CG; Nah SY; Nabeshima T; Kim HC
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):192-201. PubMed ID: 25400014
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells.
Arany I; Megyesi JK; Kaneto H; Price PM; Safirstein RL
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F543-9. PubMed ID: 15149969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
